This week, we speak with with Michel Brousset, CEO of Waldencast Acquisition Corp. (Nasdaq: WALD)
Waldencast announced a $1.2 billion three-way combination with skincare and cosmetics brands Obagi and Milk Makeup in November.
Michel has taken a different approach to SPACs, using Waldencast as a vehicle to create a platform company.
Waldencast’s management will continue to operate the combined company over a longer term while tucking in additional acquisitions to its portfolio.
We discuss the potential advantages to that strategy within the cosmetics space as well as how its first two targets, which are very different from one another, fit together in this model.
You can find our catalog of podcast episodes on both Apple and Spotify.
Vehicle data-tracker Wejo (NASDAQ:WEJO) announced in an 8-K this afternoon that it has filed its intention to appoint an administrator to oversee its insolvency and it is evaluating whether it will do so in the United States as well. The company, which completed a de-SPAC transaction with Virtuoso in November 2021, has another SPAC deal...
Aimei Health Technology Co. (NASDAQ:AFJK) filed its S-1 Friday afternoon for a $50 million IPO, marking the fourth SPAC to file for an IPO in May and the twelfth year-to-date. Given its name, it comes as no surprise that Aimei Health Technology intends to pursue prospective targets that are focused on healthcare innovation. More specifically, the...
Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. Latest SPAC News: GreenLight Biosciences returns to private market, Jet.AI partners with Vegas Golden Knights and Cirrus Aviation, and True Velocity announces partnership with FN America GreenLight returns to private market in $46M deal after taste of...
GreenLight Biosciences (NASDAQ:GRNA), which combined with Environmental Impact in February 2022, announced this morning that it is being acquired in a go-private transaction by Fall Line Capital for $45.5 million. While this is a steep valuation decline from its $1.23 billion enterprise value at the announcement of its SPAC deal, this price does represent a...
FOXO Technologies Inc. (NYSE:FOXO), which completed its business combination with Delwinds Insurance in September 2022, announced this morning that it has consummated its exchange offer for all outstanding warrants as well as its PIK note offer to amend. As part of the offer, all holders of FOXO’s warrants received 4.83 shares of Class A common...